Tocilizumab in MOG-antibody spectrum disorder: a case report.
Sign Up to like & getrecommendations! Published in 2019 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2018.11.012
Abstract: BACKGROUND Myelin oligodendrocyte glycoprotein antibody-related spectrum disorders (MOG-SD) are a heterogeneous group of inflammatory demyelinating diseases of the central nervous system, usually responsive to conventional immunosuppressive therapies. However, knowledge about treatment of non-responder patients is… read more here.
Keywords: mog antibody; antibody; spectrum; report ... See more keywords